An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 86 (4) , 255-264
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 33 references indexed in Scilit:
- The role of immune dysfunction in the pathophysiology of autismBrain, Behavior, and Immunity, 2012
- Cytokines and Neurodevelopmental Outcomes in Extremely Low Birth Weight InfantsThe Journal of Pediatrics, 2011
- The ageing systemic milieu negatively regulates neurogenesis and cognitive functionNature, 2011
- Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalystNature Protocols, 2011
- Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disordersJournal of Neuroimmunology, 2011
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcomeBrain, Behavior, and Immunity, 2011
- Combining Coma Score and Serum Biomarker Levels To Predict Unfavorable Outcome following Childhood Brain TraumaJournal of Neurotrauma, 2010
- Prevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder Among Children in the US, 2007Pediatrics, 2009
- Brain‐derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) studyAutism Research, 2008
- Immune-based regulation of adult neurogenesis: Implications for learning and memoryBrain, Behavior, and Immunity, 2008